Fortitude Family Office’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.37K Buy
+173
New +$2.36K ﹤0.01% 1940
2025
Q4
– Sell
-77
Closed -$822 – 2065
2025
Q3
$822 Hold
77
– – ﹤0.01% 1611
2025
Q2
$745 Sell
77
-297
-79% -$3.06K ﹤0.01% 1636
2025
Q1
$5.57K Hold
374
– – ﹤0.01% 702
2024
Q4
$5.58K Buy
374
+242
+183% +$3.94K ﹤0.01% 809
2024
Q3
$2.52K Buy
+132
New +$2.74K ﹤0.01% 955

Other funds holding OGN

Fortitude Family Office's OGN Position: Q3 2026 in Review

Fortitude Family Office opened a new position in Organon & Co (OGN) in Q3 2026: 173 shares worth $2.37K. The stake represents ﹤0.01% of the portfolio and ranks #1940 among its holdings. This is a return to the name: Fortitude Family Office previously reported a position in OGN as recently as Q3 2025.

Fortitude Family Office first reported a position in OGN in Q3 2024 and has held it in 6 quarters since. The position peaked at $5.58K in Q4 2024. 49 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Fortitude Family Office held 173 shares of Organon & Co worth $2.37K as of Q3 2026.
  • Organon & Co was a new Fortitude Family Office position in Q3 2026.
  • Organon & Co made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1940 holding.
  • Fortitude Family Office first reported a position in Organon & Co in Q3 2024 and has held it in 6 quarters since.
  • Fortitude Family Office's Organon & Co position peaked at $5.58K in Q4 2024.
  • 49 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.